Alternative dosing of dual PI3K and MEK inhibition in cancer therapy
© Jokinen et al.; licensee BioMed Central Ltd. 2012
Received: 29 March 2012
Accepted: 18 December 2012
Published: 21 December 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|29 Mar 2012||Submitted||Original manuscript|
|8 Jun 2012||Reviewed||Reviewer Report - Timothy Yap|
|11 Jun 2012||Reviewed||Reviewer Report - Nicolas Chapuis|
|31 Aug 2012||Author responded||Author comments - Jussi Koivunen|
|Resubmission - Version 2|
|31 Aug 2012||Submitted||Manuscript version 2|
|6 Oct 2012||Reviewed||Reviewer Report - Timothy Yap|
|9 Oct 2012||Reviewed||Reviewer Report - Nicolas Chapuis|
|30 Nov 2012||Author responded||Author comments - Jussi Koivunen|
|Resubmission - Version 3|
|30 Nov 2012||Submitted||Manuscript version 3|
|18 Dec 2012||Editorially accepted|
|21 Dec 2012||Article published||10.1186/1471-2407-12-612|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.